Amifostine-doxorubicin association causes long-term prepubertal spermatogonia DNA damage and early developmental

V Vendramini1, B Robaire, S M Miraglia

  • 1Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. vane.vanila@gmail.com

Abstract

Insights

Amifostine and doxorubicin combination therapy in male rats caused long-term sperm DNA damage and impaired embryo development. This combination raises concerns for germ cell genome integrity and reproductive outcomes.

Area of Science:

  • Reproductive Toxicology
  • Developmental Biology
  • Genetics

Background:

  • Previous research indicated amifostine partially protected seminiferous epithelium in prepubertal doxorubicin-treated rats.
  • Fertility status was not improved in adult rats previously treated with amifostine and doxorubicin.

Purpose of the Study:

  • To evaluate long-term DNA damage in spermatogonia following amifostine and doxorubicin treatment.
  • To assess the impact of this treatment on subsequent embryo development.

Main Methods:

  • Prepubertal male rats received doxorubicin, amifostine, or a combination.
  • Sperm DNA integrity was analyzed using Comet Assay and SCSA™.
  • Embryo development was assessed after mating treated males with fertile females.

Main Results:

  • Amifostine-doxorubicin treatment led to increased sperm DNA strand breaks and chromatin denaturation.
  • Both amifostine and amifostine-doxorubicin groups showed increased arrested embryos.
  • The amifostine-doxorubicin group exhibited a higher number of arrested embryos compared to the amifostine-only group.

Conclusions:

  • The combination of amifostine and doxorubicin induces long-term damage to sperm DNA in rat spermatogonia.
  • This genotoxicity compromises conceptus development and reduces pregnancy outcomes.
  • Concerns exist regarding the effects of amifostine-doxorubicin on germ cell genome integrity.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...